Views & Analysis De-busting the myths about medical cannabis Medical cannabis has quickly become the most socially disruptive phenomenon of the new millennium, and it is showing no signs of slowing.
Views & Analysis Addressing the medical cannabis knowledge gap The legalisation of medical cannabis in November 2018 was hailed as a landmark victory for the British medical industry, with scientists, researchers and patients alike all welcoming the ch
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.